A prospective evaluation of lymphatic dissemination in endometrial cancer : Is it adequate to perform lymph node dissection up to the inferior mesenteric artery?

International Journal of Gynecological Cancer

Volumn 21, Issue 5, 2011, Pages 864-869

  Turan, Taner ^a   Ynlmaz, Saynur Sarncn ^a,c   Hnzln, Deniz ^a   Gündoǧdu, Burcu ^a   Boran, Nurettin ^a   Tulunay, Gökhan ^a   Özfuttu, Ahmet ^b   Köse, M Faruk ^a  

^a Gynecological Oncology Unit   (Turkey)

^b Pathology Divisions   (Turkey)

^c Tevfik Sa lam Cad 89 7 Etlik   (Turkey)

Author keywords

Endometrial cancer; Inferior mesenteric artery; Lymphadenectomy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER SURGERY; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; DATA ANALYSIS SOFTWARE; DISEASE SEVERITY; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; INFERIOR MESENTERIC ARTERY; INFERIOR MESENTERIC ARTERY METASTASIS; KIDNEY BLOOD VESSEL; KIDNEY VEIN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MEDICAL RECORD; MESENTERIC ARTERY; MYOMETRIUM; PARAAORTIC LYMPH NODE; PARAAORTIC LYMPH NODE METASTASIS; PARAAORTIC LYMPHADENECTOMY; PATHOPHYSIOLOGY; PELVIS LYMPHADENECTOMY; POSTOPERATIVE PERIOD; PRESACRAL MESENTERIC ARTERY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 82955186864     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31821a3665     Document Type: Article

References (25)

1. Announcements: FIGO (the International Federation of Obstetricians and Gynecologists) stages: 1988 revision. Gynecol Oncol. 1989;35:125-126.
2. Mariani A,Webb MJ, Galli L, et al. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol. 2000;76:348-356. (Pubitemid 30131506)
3. Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer. 1987;60: 2035-2041. (Pubitemid 17145924)
4. Kilgore LC, Partridge EE, Alvarez RD, et al. Adenocarcinoma of the endometrium: Survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol. 1995;56:29-33.
5. Takeshima N, Hirai Y, Tanaka N, et al. Pelvic lymph node metastasis in endometrial cancer with no myometrial invasion. Obstet Gynecol. 1996;88:280-282. (Pubitemid 26250306)
6. Meeting Report. The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas. Gynecol Oncol. 2009;115:325-328.
7. Frederick PJ, Straughn JM Jr. The role of comprehensive surgical staging in patients with endometrial cancer. Cancer Control. 2009;16:23-29.
8. Announcement. FIGO stagesV1988 revision. Gynecol Oncol. 1989;35:125-127.
9. Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, et al. Current issues in the management of endometrial cancer. Mayo Clin Proc. 2008;83:97-112.
10. Bernardini MQ, Murphy JK. Issues surrounding lymphadenectomy in the management of endometrial cancer. J Surg Oncol. 2009;99:232-241.
11. Fujimoto T, Nanjyo H, Nakamura A, et al. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIC endometrial cancer. Gynecol Oncol. 2007;107:253-259. (Pubitemid 47575722)
12. Hirahatake K, Hareyama H, Sakuragi N, et al. A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. J Surg Oncol. 1997;65:82-87. (Pubitemid 27283917)
13. Mariani A, Keeney GL, Aletti G, et al. Endometrial carcinoma: Paraaortic dissemination. Gynecol Oncol. 2004;92:833-838. (Pubitemid 38251385)
14. Watari H, Todo Y, Takeda M, et al. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Gynecol Oncol. 2005;96:651-657. (Pubitemid 40255483)
15. Mariani A, Dowdy SC, ClibyWA, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical staging. Gynecol Oncol. 2008;109:11-18.
16. Fotopoulou C, Savvatis K, Kraetschell R, et al. Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: Lymph-node mapping and identification of predictive factors for lymph-node status. Eur J Obstet Gynecol Reprod Biol. 2010;149:199-203.
17. Watanabe Y, Aoki D, Kitagawa R, et al. Disease Committee of Uterine Endometrial Cancer, Japanese Gynecologic Oncology Group. Status of surgical treatment procedures for endometrial cancer in Japan: Results of a Japanese Gynecologic Oncology Group survey. Gynecol Oncol. 2007;105:325-328. (Pubitemid 46590323)
18. Yokoyama Y, Maruyama H, Sato S, et al. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol Oncol. 1997;64:411-417. (Pubitemid 27120428)
19. Lécuru F, Neji K, Robin F, et al. Lymphatic drainage of the uterus: Preliminary results of an experimental study [in French]. J Gynecol Obstet Biol Reprod (Paris). 1997;26:418-423.
20. Burke TW, Levenback C, Tornos C, et al. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: Results of a pilot study. Gynecol Oncol. 1996;62: 169-173. (Pubitemid 26274795)
21. Maccauro M, Lucignani G, Aliberti G, et al. Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer. Eur J Nucl Med Mol Imaging. 2005;32: 569-574. (Pubitemid 41214200)
22. Soliman PT, Frumovitz M, Spannuth W, et al. Lymphadenectomy during endometrial cancer staging: Practice patterns among gynecologic oncologists. Gynecol Oncol. 2010;119:291-294.
23. Malzoni M, Tinelli R, Cosentino F, et al. Total laparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy for early-stage endometrial cancer: A prospective randomized study. Gynecol Oncol. 2009;112:126-133.
24. Todo Y, Kato H, Kaneuchi M, et al. Survival Effect of Para-Aortic Lymphadenectomy in Endometrial Cancer (SEPAL study): A retrospective cohort analysis. Lancet. 2010;375:1165-1172.
25. ASTEC Study Group, Kitchener H, Swart AM, Qian Q, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomised study. Lancet. 2009;373:125-136.